No Data
Kose RE, Hagiwara Kogyo, Subaru Koro, Sea IC (9th)
The above calendar is only a schedule and may change due to corporate circumstances.---------------------------------------December 9 (Monday) <2163> Altner <2301> Gakujo <2438> Asukanet <2991> Landnet <3071> Stream <3180> B Garage <3246> Kosei RE <4238> Mirai Ar <6387> Sa
Stocks that moved the previous day part1: Kaiom, Jayck, Grandies, etc.
Stocks that moved the previous day part1: Kayoum, Jekk, Grandees, and other stocks <Code> 25th closing price ⇒ Previous day comparison J Front <3086> 1534.5 +18.25 Revised upwards the performance and dividend estimates for the fiscal year ending February 2025. After opening high, it lost momentum. GENDA <9166> 2373 -134 Profit-taking sales dominant despite confirmation of Leo's 5.17% shareholding. Kayoum <4583> 114 +2 Business partnership with Merck & Co. in antibody production outsourcing services, etc. Jekk <7073> 2310
Emerging markets stock digest: GENDA continues to decline significantly, while Jayck rebounds significantly.
<9166> GENDA 2373 -134 significantly continues to decline. Leos Capital Works, a subsidiary of SBI Reos Hifumi <165A> (Chiyoda-ku, Tokyo), has revealed in a large shareholding report based on the 5% rule that they hold 5.17% (3,930,9800 shares) of GENDA stock. In the morning, buying took the lead, but later profit-taking selling prevailed. The obligation to report occurred on the 13th, with the purpose of holding being "investment trust agreement" and "investment trust agreement commission" based net.
Hot stocks digest (morning session): Nisshin Pharmaceutical, CYBOZU, Shiseido Company,Limited Sponsored ADR, etc.
Nisshin Pharma <4516>: 3830 yen (+442 yen) significantly extended. J&J has announced that it has obtained manufacturing and sales approval for the combination drug "Yubanshi Combination Tablets", which combines the endothelin receptor antagonist macitentan 10mg and the phosphodiesterase 5 inhibitor tadalafil 40mg, for the treatment of pulmonary arterial hypertension. Positive movements towards expanding into the field of pulmonary hypertension, which is positioned as one of the areas of focus, are taking the lead. shiseido company,limited sponsored adr <4911>
JAC - significantly rebounded, with over 3,000 national certified career consultants registered on the interview platform.
Marked rebound. The Career Counseling Platform "Kakedas," operated by a group company, has announced that the number of nationally certified career consultants registered has exceeded 3,000. The increase in demand for career consultants from companies and government agencies is cited as the reason behind this. The number of active career consultants has also increased, and the number of consultations on the same platform exceeded 580% year-on-year in August.
Stocks that moved the previous day part 1: Jayk, Kawasaki Heavy Industries, Japan M&A, etc.
Share price name <code> 13-day closing price ⇒ Previous day's SYSHD＜3988＞ 533 +48 Operating profit is expected to increase by 31.6% over the previous period and by 16.8% in the current period. Ishihara Chemicals＜4462＞ 2285 +104 announced a share buyback of up to 6.25% of the issued shares and a share cancellation of 2.32%. ispace＜9348＞ 731 +16 The launch of the "HAKUTO-R" Mission 2 is scheduled for December 2024 at the fastest. Jayc＜7073＞ 2374 +400 The operating profit for the first half increased by 0.6.